300 filings
Page 4 of 15
8-K
j4f5wkh
23 Nov 21
Oragenics Announces Adjournment of Annual Meeting of Shareholders
9:05am
8-K
07k6epn i6
12 Nov 21
Regulation FD Disclosure
12:00am
8-K
v9qgah9ptqzlxc1io9
4 Oct 21
Other Events
7:59am
8-K
jnuxsqlz
24 Sep 21
Termination of a Material Definitive Agreement
4:23pm
8-K
j32l606wxos9by9m9
15 Sep 21
Oragenics Initiates COVID-19 Challenge Study Evaluating Multiple Formulations of its SARS-CoV-2 Vaccine Candidate
9:08am
8-K
jn0dl
3 Sep 21
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:05pm
8-K
v7iuci vtx3gv
30 Aug 21
Other Events
7:42am
8-K
e2cy4ps2gkrxhrzn
24 Aug 21
Oragenics Announces Postponement of Annual Meeting of Shareholders
7:44am
8-K
oze5qr6cp6ye
27 Jul 21
Entry into a Material Definitive Agreement
7:27am
8-K
c91jmf6yow
1 Jul 21
Oragenics Announces Adjournment of Annual Meeting of Shareholders
7:59am
8-K
4nqum4f8e
18 May 21
Oragenics Issues Letter to Shareholders
8:16am
8-K
jrnbn4c9wo ofhlfo
3 May 21
Oragenics Announce Changes in Management and Board of Directors
9:00am
8-K
18596xnt cwg1tk
1 Apr 21
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:58pm
8-K
2dkxcw0
9 Mar 21
Regulation FD Disclosure
7:15am
8-K
45ngqfq2kqoflr
5 Mar 21
Other Events
5:10pm
8-K
3tdmk
19 Feb 21
Departure of Directors or Certain Officers
4:05pm
8-K
yhbdq52j 277d
12 Feb 21
Oragenics Announces Recent Capital Raise and Warrant Exercises Totaling $21.9 Million and the Redemption of Its Series C Preferred Stock
8:16am
8-K
11lu8ib3lmcnkxs
2 Feb 21
Other Events
8:10am
8-K
ivfcfnwn24u3
1 Feb 21
Entry into a Material Definitive Agreement
5:03pm
8-K
vsof 7qb6
14 Jan 21
Oragenics Issues Letter to Stockholders
7:14am